{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:05:27Z","timestamp":1753877127724,"version":"3.41.2"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"1","funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Identifying tuberculosis infection (TBI) using interferon-gamma release assays (IGRAs) is a primary component of clinical and public health efforts to prevent pediatric tuberculosis (TB). Pediatric data comparing the 2 IGRAs in the United States are very limited. We compared the performance of the 2 IGRAs among a large pediatric cohort tested for TBI and assessed whether discordance might be due to quantitative results close to test cutoff values.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Children aged 0-15 years with both T-SPOT.TB (T-SPOT) and QuantiFERON-TB Gold In-Tube (QFT-GIT) tests were identified from a US multicenter study enrolling people at elevated risk of TBI or progression to TB disease. Results were compared using McNemar\u2019s Chi-square tests with stratification by age category and testing reason. Percent agreement and kappa statistics were also calculated. We characterized quantitative test results among children with discordant QFT-GIT-positive\/T-SPOT-negative results.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 3793 children, a higher number had positive QFT-GIT than T-SPOT (10.1% vs 7.4%, P\u2005&amp;lt;\u2005.001). This difference was noted for all age categories except &amp;lt;2 years, and for children with close-contact and non-close contact test indications. Among discordant QFT-GIT-positive\/T-SPOT-negative children, lowering the positive threshold for T-SPOT to include borderline spot counts (5-7) did not eliminate the discordance, nor were QFT-GIT antigen-minus-nil results concentrated in the range just above the standard cutoff of 0.35 IU\/mL.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In a large pediatric cohort tested for TBI, QFT-GIT had a higher proportion of positive results than T-SPOT, and discordance was not related to quantitative results close to the established diagnostic cutoffs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jpids\/piae135","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T13:15:47Z","timestamp":1735910147000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Two Interferon-Gamma Release Assays for Pediatric Tuberculosis Infection"],"prefix":"10.1093","volume":"14","author":[{"given":"James T","family":"Gaensbauer","sequence":"first","affiliation":[{"name":"Mayo Clinic Center for Tuberculosis, Mayo Clinic , Rochester, MN ,","place":["United States"]},{"name":"Division of Pediatric Infectious Diseases, Department of Pediatrics and Adolescent Medicine, Mayo Clinic , Rochester, MN ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall R","family":"Reves","sequence":"additional","affiliation":[{"name":"Denver Metro Tuberculosis Clinic , Denver, CO ,\u00a0","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolly","family":"Katz","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, Centers for Disease Control and Prevention , Atlanta, GA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amina","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases and Immunology, Department of Pediatrics, Levine Children\u2019s Hospital , Charlotte, NC ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thara","family":"Venkatappa","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, Centers for Disease Control and Prevention , Atlanta, GA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"key":"2025012114110066200_CIT0001","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1001\/jama.2023.4899","article-title":"Screening for latent tuberculosis infection in adults: US preventive services task force recommendation statement","volume":"329","author":"Mangione","year":"2023","journal-title":"JAMA."},{"key":"2025012114110066200_CIT0002","doi-asserted-by":"publisher","first-page":"e1002824","DOI":"10.1371\/journal.pmed.1002824","article-title":"Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries","volume":"16","author":"Campbell","year":"2019","journal-title":"PLoS Med"},{"key":"2025012114110066200_CIT0003","doi-asserted-by":"publisher","first-page":"e2021054663","DOI":"10.1542\/peds.2021-054663","article-title":"Tuberculosis infection in children and adolescents: testing and treatment","volume":"148","author":"Nolt","year":"2021","journal-title":"Pediatrics."},{"key":"2025012114110066200_CIT0004","doi-asserted-by":"crossref","first-page":"e20191930","DOI":"10.1542\/peds.2019-1930","article-title":"Interferon-gamma release assays in children &lt;15 years of age","volume":"145","author":"Ahmed","year":"2020","journal-title":"Pediatrics."},{"key":"2025012114110066200_CIT0005","first-page":"888","article-title":"Tuberculosis","volume-title":"Red Book: 2024\u20132027 Report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics, Section on Infectious Disease","year":"2024"},{"key":"2025012114110066200_CIT0006","doi-asserted-by":"publisher","first-page":"e20183327","DOI":"10.1542\/peds.2018-3327","article-title":"The case for retiring the tuberculin skin test","volume":"143","author":"Cruz","year":"2019","journal-title":"Pediatrics."},{"key":"2025012114110066200_CIT0007","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/cid\/ciw778","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention Clinical Practice Guidelines: diagnosis of tuberculosis in adults and children","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2025012114110066200_CIT0008","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1183\/09031936.00115110","article-title":"Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis","volume":"37","author":"Diel","year":"2011","journal-title":"Eur Respir J"},{"key":"2025012114110066200_CIT0009","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12879-023-08008-2","article-title":"Comparing the diagnostic performance of QuantiFERON-TB Gold Plus with QFT-GIT, T-SPOT.TB and TST: a systematic review and meta-analysis","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Infect Dis"},{"key":"2025012114110066200_CIT0010","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1128\/CVI.00364-07","article-title":"Comparison of two commercially available gamma interferon blood tests for immunodiagnosis of tuberculosis","volume":"15","author":"Dominguez","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"2025012114110066200_CIT0011","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10238-014-0296-3","article-title":"Influential factors of the performance of interferon-gamma release assays in the diagnosis of childhood tuberculosis","volume":"15","author":"Li","year":"2015","journal-title":"Clin Exp Med"},{"key":"2025012114110066200_CIT0012","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1186\/1471-2334-14-S1-S6","article-title":"Systematic review and meta-analysis on the utility of Interferon-gamma release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a 2013 update","volume":"14","author":"Sollai","year":"2014","journal-title":"BMC Infect Dis"},{"author":"Centers for Disease Control and Prevention","key":"2025012114110066200_CIT0013"},{"key":"2025012114110066200_CIT0014","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1473-3099(21)00145-6","article-title":"Comparison of three tests for latent tuberculosis infection in high-risk people in the USA: an observational cohort study","volume":"22","author":"Ho","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2025012114110066200_CIT0015","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1001\/jama.300.4.405","article-title":"Tuberculosis among foreign-born persons in the United States","volume":"300","author":"Cain","year":"2008","journal-title":"JAMA."},{"year":"2018","author":"Qiagen","key":"2025012114110066200_CIT0016"},{"year":"2019","author":"Oxford Immunotec","key":"2025012114110066200_CIT0017"},{"key":"2025012114110066200_CIT0018","doi-asserted-by":"publisher","first-page":"e0137021","DOI":"10.1128\/JCM.01370-21","article-title":"The impact of borderline Quantiferon-TB gold plus results for latent tuberculosis screening under routine conditions in a low-endemicity setting","volume":"59","author":"Wikell","year":"2021","journal-title":"J Clin Microbiol."},{"key":"2025012114110066200_CIT0019","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1164\/rccm.201302-0365OC","article-title":"Interferon-gamma release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States","volume":"189","author":"Dorman","year":"2014","journal-title":"Am J Respir Crit Care Med."},{"key":"2025012114110066200_CIT0020","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1128\/JCM.01136-11","article-title":"Preanalytical delay reduces sensitivity of QuantiFERON-TB gold in-tube assay for detection of latent tuberculosis infection","volume":"49","author":"Doberne","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2025012114110066200_CIT0021","doi-asserted-by":"publisher","first-page":"e7972","DOI":"10.1371\/journal.pone.0007972","article-title":"Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis","volume":"4","author":"Smith","year":"2009","journal-title":"PLoS One"},{"key":"2025012114110066200_CIT0022","doi-asserted-by":"publisher","first-page":"e00120","DOI":"10.1128\/JCM.00120-21","article-title":"Impact of T-Cell Xtend on T-SPOT.TB assay in high-risk individuals after delayed blood sample processing","volume":"59","author":"Feng","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2025012114110066200_CIT0023","doi-asserted-by":"publisher","first-page":"e0055122","DOI":"10.1128\/jcm.00551-22","article-title":"Novel automation of an enzyme-linked immunosorbent spot assay testing method: comparable diagnostic performance of the T-SPOT.TB test using manual density gradient cell isolation versus automated positive selection with the T-Cell select kit","volume":"60","author":"Wang","year":"2022","journal-title":"J Clin Microbiol"},{"key":"2025012114110066200_CIT0024","doi-asserted-by":"publisher","first-page":"e00985-19","DOI":"10.1128\/JCM.00985-19","article-title":"Comparing QuantiFERON-TB Gold Plus with other tests to diagnose Mycobacterium tuberculosis infection","volume":"57","author":"Venkatappa","year":"2019","journal-title":"J Clin Microbiol"},{"journal-title":"Tuberculosis Epidemiologic Studies Consortium (TBESC)-II Part A: comparison of the tuberculin skin test and interferon-gamma release assays in diagnosing infection with Mycobacterium tuberculosis and prediction of progression to tuberculosis disease","year":"2024","author":"Centers for Disease Control and Prevention","key":"2025012114110066200_CIT0025"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpids\/advance-article-pdf\/doi\/10.1093\/jpids\/piae135\/61324433\/piae135.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/14\/1\/piae135\/61324433\/piae135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/14\/1\/piae135\/61324433\/piae135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T14:11:12Z","timestamp":1737468672000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/doi\/10.1093\/jpids\/piae135\/7942144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,20]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piae135","relation":{},"ISSN":["2048-7207"],"issn-type":[{"type":"electronic","value":"2048-7207"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2025,1]]},"article-number":"piae135"}}